Head-to-head · WeighScore
Ivim Health vs The Virtual NP
The verdict
The Virtual NP takes it — 60.8/100 to 59.6/100, but only just.
The Virtual NP grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Virtual NP is a nurse-practitioner-led telehealth weight loss clinic prescribing FDA-approved branded GLP-1 medications, Zepbound (tirzepatide) and Wegovy (semaglutide), from Eli Lilly and Novo Nordisk. Ivim Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ivim Health | The Virtual NP |
|---|---|---|
| WeighScore | 59.6/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #338 | #314 |
| Semaglutide | $149/mo (starting dose, medication and programme fee, compounded) | Not disclosed |
| Tirzepatide | $224/mo (starting dose, medication and programme fee, compounded) | Not disclosed |
| Coverage | Coverage not published | 7 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #338 · C
Strengths
- Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
Where it loses points
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
- Both figures are 'starting at' rates, so the cost of a titrated dose is not published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #314 · C
Strengths
- FDA-approved branded Zepbound and Wegovy only, no compounded
- Transparent fees: 99 visit or 75 per month membership
- HSA/FSA accepted and prior authorization assistance offered
- NP-led with same or next-day booking and home shipping
Where it loses points
- Branded only, so medication cost is high and billed separately
- Limited to seven states
- No compounded lower-cost GLP-1 alternative
- Single-provider practice may limit scale and hours
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.